<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>OICC Press</PublisherName>
<JournalTitle>Trends in Phytochemical Research</JournalTitle>
<Issn>2588-3631</Issn>
<Volume>2</Volume>
<Issue>2</Issue>
<PubDate PubStatus="epublish">
<Year>2018</Year>
<Month>06</Month>
<Day>01</Day>
</PubDate>
</Journal>
<ArticleTitle>Antihyperlipidemic activity of a unani formulation in high fat diet-induced obese murine model</ArticleTitle>
<VernacularTitle></VernacularTitle>
<FirstPage>83</FirstPage>
<LastPage>90</LastPage>
<ELocationID EIdType="doi"></ELocationID>
<Language>EN</Language>
<AuthorList>
<Author>
<FirstName>Md Rafiul</FirstName>
<LastName>Haque</LastName>
<Affiliation>Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard, Hamdard Nager, New Delhi 62, India</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Shahid Hussain</FirstName>
<LastName>Ansari</LastName>
<Affiliation>HIMT college of Pharmacy, Gr. Noida (U.P), India</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
</AuthorList>
<PublicationType>Journal Article</PublicationType>
<History>
<PubDate PubStatus="received">
<Year>2018</Year>
<Month>06</Month>
<Day>01</Day>
</PubDate>
</History>
<Abstract>Arq zeera (AZ), a poly herbal unani formulation has been used traditionally as a remedy for reducing body fat and gastric disorder. The current study was designed to investigate the antihyperlipidemic activity of AZ against rat model of high fat diet (HFD) - induced obesity. AZ was prepared and administered orally 7.75 ml/kg/twice a day for 4 weeks to HFD- induced obese rat. Body weight and serum biomarkers were evaluated. Stability testing of AZ was also carried out. At the end of study, HFD significantly (p &amp;lt; 0.001) increased body weight, cholesterol, triglycerides, pancreatic lipase activity and malondialdehyde (MDA) levels as compared to normal diet control group. AZ-treated rats significantly (p &amp;lt; 0.001) reduced body weights, cholesterol, triglycerides, pancreatic lipase activity and MDA levels as compared to HFD control. These results suggest that AZ has an antihyperlipidemic action against HFD-induced obesity in rats, possibly through lipid lowering action, reduction of intestinal absorption of dietary fat, and increased antioxidant defense.</Abstract>
<ObjectList>
<Object Type="keyword">
<Param Name="value">High fat diet</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Unani formulation</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Pancreatic lipase</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Arq Zeera</Param>
</Object>
<Object Type="keyword">
<Param Name="value">body weight</Param>
</Object>
</ObjectList>
</Article>
</ArticleSet>